Methods for Assessing the Effects of LXR Agonists on Macrophage Bacterial Infection

Estibaliz Glaría1,2, Jonathan Matalonga1, Annabel F Valledor3,4

  • 1Nuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Barcelona, Spain.

Insights

This study explores how the LXR pathway impacts bacterial infections in macrophages. Protocols are detailed to measure how this pathway affects macrophage bacterial killing and intracellular pathogen survival.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Macrophages are crucial immune cells for engulfing and eliminating pathogens via the phagolysosomal system.
  • Certain pathogenic bacteria have evolved mechanisms to evade phagolysosomal destruction and replicate intracellularly within macrophages.
  • Understanding host-pathogen interactions within macrophages is vital for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the role of the Liver X Receptor (LXR) pathway in modulating the outcome of bacterial infections within macrophages.
  • To provide detailed experimental protocols for assessing the LXR pathway's influence on macrophage antimicrobial functions.
  • To elucidate how LXR activation or inhibition affects the intracellular survival and replication of pathogenic bacteria.

Main Methods:

  • Isolation and culture of murine bone marrow-derived macrophages.
  • Infection of macrophages with specific pathogenic bacterial species.
  • Quantification of bacterial load within macrophages over time.
  • Assessment of macrophage phagocytic and killing activity.
  • Molecular analysis of LXR pathway activation and downstream signaling.

Main Results:

  • The study details methods to quantify bacterial burden and macrophage responses.
  • Results demonstrate how modulating the LXR pathway influences bacterial clearance or survival.
  • Specific protocols allow for the measurement of LXR's impact on the intracellular fate of bacteria within macrophages.

Conclusions:

  • The LXR pathway significantly influences the ability of macrophages to control bacterial infections.
  • The provided protocols enable researchers to dissect the molecular mechanisms underlying LXR-mediated host defense against intracellular bacteria.
  • Targeting the LXR pathway may represent a novel therapeutic approach to combat bacterial infections that establish intracellular niches.

Related Concept Videos

Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
660
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
902
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.6K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K